---
title: "How do anti-VEGF medications compare (Avastin vs Lucentis vs Eylea)?"
description: "Avastin, Lucentis, and Eylea are anti-VEGF injections used to treat conditions like wet AMD and diabetic macular oedema. They work in similar ways but differ slightly in licensing, dosing, and cost. ## Similarities and differences All three drugs block vascular…"
url: "https://bluefinvision.com/knowledge-base/topics/treatments-procedures/how-do-anti-vegf-medications-compare-avastin-vs-lucentis-vs-eylea/"
updated: "2025-12-16"
category: "Treatments & Procedures"
---

# How do anti-VEGF medications compare (Avastin vs Lucentis vs Eylea)?

Avastin, Lucentis, and Eylea are anti-VEGF injections used to treat conditions like wet AMD and diabetic macular oedema. They work in similar ways but differ slightly in licensing, dosing, and cost.

## Similarities and differences

All three drugs block vascular endothelial growth factor to reduce leakage and swelling. Many patients achieve comparable visual outcomes.

- Lucentis and Eylea are specifically licensed for eye use
- Avastin is used off-label in ophthalmology but widely studied
- Eylea may allow slightly longer treatment intervals for some conditions
- Choice can depend on national guidelines, availability, and funding

## Practical considerations

Your clinician will recommend a regimen based on your eye response. Switching between agents is sometimes helpful.

- Regular OCT scans track fluid and guide injection timing
- Side effects and risks, including infection, are similar and very low
- Cost differences may influence first-line choices in some health systems
- Discuss concerns about frequency, travel, and long-term treatment early on